Redmile Group LLC 13D and 13G filings for Ayala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 5:16 pm Sale |
2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 0 0.000% |
-1,472,522 (Position Closed) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,472,522 9.900% |
91,445 (+6.62%) |
Filing |
| 2021-03-02 4:10 pm Purchase |
2021-02-23 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,381,077 9.990% |
713,261 (+106.81%) |
Filing |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 667,816 5.200% |
667,816 (New Position) |
Filing |